Xspray Pharma AB's total assets for Q3 2025 were kr820.20M, an increase of 17.68% from the previous quarter. SE:XSPRAY total liabilities were kr178.47M for the fiscal quarter, a 10.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.